Digital musculoskeletal care company SWORD Health has adopted dr. Vijay Yanamadala as chief physician.
Yanamadala is a spinal neurosurgeon and is currently the Systemwide Medical Director of Spine Quality and Surgical Optimization at Hartford Healthcare in Connecticut.
“Like my clinical approach, SWORD meets with patients where they need to provide solutions that focus on strong outcomes. Offering members non-surgical alternatives and effective solutions can help improve their health, eliminate their MSK pain, and improve their quality of life.” I am excited to join SWORD and help the team achieve a very valuable mission for healthcare and for the world at large,” Yanamadala said in a statement.
The digital MSK and physiotherapy room attracted a lot of interest from investors last year. SWORD raised multiple funding rounds in 2021, including $163 million in Series D funding plus a secondary round of $26 million that boosted the valuation to $2 billion.
Personal electrocardiogram maker AliveCor appointed Patricia Baran as senior vice president, Healthcare Americas.
Baran will manage sales to customers of employers, payers and health systems. She most recently served as vice president of central region health systems at telehealth giant Teladoc Health, joining when it merged with chronic care management company Livongo.
“Patti has had a broad impact in the health technology industry and will provide a new perspective for our teams during this pivotal time in our company’s evolution,” said Vincent Balsamo, AliceCor’s Executive Vice President of Worldwide Sales in a statement.
“As we continue to expand into new markets, Patti’s experience launching integrated digital health solutions will be instrumental in achieving our long-term vision to provide end-to-end cardiac care to healthcare providers, payers, employers and patients much further along. beyond our industry-leading devices.”
Balsamo joined the company in December along with several new executive team hires starting in 2021. Earlier this month, AliveCor introduced a credit card-sized personal EKG called KardiaMobile.
Socially determinedproviding a platform that helps healthcare organizations find social and environmental issues affecting patient populations, announced two new hires to the executive team.
Paul Matsui will serve as Chief Strategy Officer and join the Advisory Board Company’s Socially Determined. Most recently, he served as executive director of data analytics research and technology activities.
Mike Considine comes to the company from TransUnion, where he was vice president of enterprise healthcare product initiatives. He will take over the role of chief product officer at Socially Determined.
“We’re at a point in the company’s journey where it’s time to sharpen our focus even more, scale our capabilities, and bring what we’ve developed and learned to even more organizations craves for the insights we’ve learned. offer,” said the company’s CEO and co-founder. dr. Trenor Williams said in a statement.
“I can’t think of two people better suited to help us achieve these goals than Paul and Mike. Their past experiences and achievements align uniquely with our mission to use social risk intelligence to improve business performance, improve clinical outcomes and health equity, and we are thrilled to have them on our team.”
Virtual Surgery Platform Proximity has spawned Charlie H. Wilhelm as general manager for America and Dave Hermann as Chief Growth Officer.
Wilhelm comes to the company from KARL STORZ Endoscopy America where he was president and COO. Herrmann previously served as global head of digital solutions for Johnson & Johnson Medtech.
“Charlie and Dave’s proven track record adds material value to Proximie and will help us achieve our mission to create a future of truly connected surgical care. Charlie will be vital to our growth in America, where we already have a significant presence. Dave will play a key role in leading our partnership strategy and supporting our overall platform growth. They are the perfect additions at the perfect time,” said Proximie CEO and Co-Founder Dr. Nadine Hachach-Haram in a statement.
In April, the company announced that it had raised money $38 million in Series B financing.